Comparison of ceftizoxime versus combination therapy in the treatment of pelvic inflammatory disease (PID).
Wikler
M A
MA
Smith Kline and French Laboratories, Philadelphia, PA, USA.
Moonsammy
G I
GI
Hemsell
D L
DL
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015296:Ceftizoxime / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004318:Doxycycline / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D015296:Ceftizoxime; D004318:Doxycycline